Novo Nordisk's insulin is more expensive than peers, yet insurance makes it more accessible
Diabetes affects around 422 million (Mn) people globally, with the majority residing in low- and middle-income countries3. Diabetes is directly responsible for 1.5 Mn deaths per year3. Insulin therapy is frequently used to treat diabetes4. Access ...
Register to read the full analysis —or— Upgrade to access more features
#cost
#price
#pricing
#returns
Actual Direct Impact
Assess the impact materiality of this Topic for Novo Nordisk
How negative/positive is the impact of Novo Nordisk for this Topic?
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.